TR1801-ADC in Patients With Tumors That Express c-Met

NCT03859752 · clinicaltrials.gov ↗

PHASE1

Phase

SUSPENDED

Status

15

Enrollment

INDUSTRY

Sponsor class

Stopped Financial funds were withdrawn by investors and study was stopped

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

BIOLOGICAL: TR1801-ADC

Sponsor

Open Innovation Partners, Inc.